Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1465-993X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis ; volume:19 ; number:1 ; day:26 ; month:6 ; year:2018 ; pages:1-12 ; date:12.2018
Respiratory research ; 19, Heft 1 (26.6.2018), 1-12, 12.2018

Urheber
Kato, Shinpei
Beteiligte Personen und Organisationen
Inui, Naoki
Hakamata, Akio
Suzuki, Yuzo
Enomoto, Noriyuki
Fujisawa, Tomoyuki
Nakamura, Yutaro
Watanabe, Hiroshi
Suda, Takafumi
SpringerLink (Online service)

DOI
10.1186/s12931-018-0831-y
URN
urn:nbn:de:101:1-2018090118175839807654
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
11.06.2025, 13:54 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Kato, Shinpei
  • Inui, Naoki
  • Hakamata, Akio
  • Suzuki, Yuzo
  • Enomoto, Noriyuki
  • Fujisawa, Tomoyuki
  • Nakamura, Yutaro
  • Watanabe, Hiroshi
  • Suda, Takafumi
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis

Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice

Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice

CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis

CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis

Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice

Nitric oxide exerts protective effects against bleomycin-induced pulmonary fibrosis in mice

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice

Verbundene Objekte